BOCA RATON, Fla., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the ...

Entero has signed a binding term sheet in which private biotech Journey is slated to acquire 99% of Entero’s equity, ...

Ademi LLP is investigating Entero (Nasdaq: ENTO) for possible breaches of fiduciary duty and other violations of law in its ...

Entero Therapeutics (ENTO) has entered into a binding term sheet for a reverse merger transaction with Journey Therapeutics. Upon completion of ...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.99% of ...

Shares of several companies including BHEL, L&T, Eicher Motors, Vodafone Idea, Entero Health, among others, will be in the ...

What Entero Healthcare Solutions Does? Entero operates one of India's largest and fastest-growing pharmaceutical distribution ...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Entero Therapeutics, Inc. (NASDAQ: ENTO) and Journey Therapeutics, Inc. is fair to Entero shareholders. Upon ...

In the wake of a historic U.S. election, global markets have shown robust performance, with major indices like the S&P 500 and Nasdaq Composite reaching record highs amid expectations of favorable ...

In the leadup to the Nov. 1 implementation of Gov. Greg Abbott’s executive order requiring Texas public hospitals to report ...

Republicans had a big night in South Texas, flipping predominately Hispanic counties along the US-Mexico border. The area has ...